What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Ayalew Tefferi mainly investigates Internal medicine, Myelofibrosis, Immunology, Surgery and Essential thrombocythemia.
His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His Myelofibrosis research includes elements of Myeloid, Myeloproliferative Disorders, Janus kinase 2 and Polycythemia vera.
His study in Immunology is interdisciplinary in nature, drawing from both Cancer research and Chronic eosinophilic leukemia.
His Surgery research includes themes of Adverse effect, Anemia and Hazard ratio.
His work investigates the relationship between Essential thrombocythemia and topics such as Myeloproliferative neoplasm that intersect with problems in Clinical trial.
His most cited work include:
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. (2498 citations)
- A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome (1452 citations)
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis (892 citations)
What are the main themes of his work throughout his whole career to date?
Ayalew Tefferi focuses on Internal medicine, Myelofibrosis, Gastroenterology, Immunology and Essential thrombocythemia.
His Internal medicine study combines topics in areas such as Surgery, Oncology and Pathology.
His Myelofibrosis research focuses on Myeloid and how it relates to Metaplasia.
The study incorporates disciplines such as Neutropenia, Leukocytosis, Myelodysplastic syndromes, Univariate analysis and Survival analysis in addition to Gastroenterology.
His Immunology study often links to related topics such as Disease.
Essential thrombocythemia is a subfield of Polycythemia vera that Ayalew Tefferi investigates.
He most often published in these fields:
- Internal medicine (54.12%)
- Myelofibrosis (38.05%)
- Gastroenterology (26.46%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (54.12%)
- Myelofibrosis (38.05%)
- Oncology (15.11%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Myelofibrosis, Oncology, Myeloproliferative neoplasm and Cancer research.
The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways.
His Myelofibrosis research integrates issues from Clinical trial, Survival analysis, Cohort and Polycythemia vera.
His studies in Oncology integrate themes in fields like International Prognostic Scoring System, Chronic myelomonocytic leukemia, Monocytosis and Survival rate.
His Myeloproliferative neoplasm research incorporates themes from Venetoclax, Chronic neutrophilic leukemia, Hypomethylating agent and Thrombocytosis.
He mostly deals with Myeloid in his studies of Cancer research.
Between 2017 and 2021, his most popular works were:
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet (185 citations)
- The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. (127 citations)
- MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis (85 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary areas of investigation include Internal medicine, Myelofibrosis, Oncology, Chronic myelomonocytic leukemia and Polycythemia vera.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
The concepts of his Myelofibrosis study are interwoven with issues in Risk assessment, Cohort and Mutation.
His Oncology research incorporates elements of Karyotype, Myeloid, Monocytosis, Myelodysplastic syndromes and Leukemia.
His Chronic myelomonocytic leukemia research entails a greater understanding of Immunology.
The various areas that he examines in his Polycythemia vera study include Thrombosis and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
